Measuring What Works: The New Frontier of Econometrics
Andrei Mihai
During a COVID-19 vaccine trial Joshua D. Angrist found inspiration to rethink clinical research design. At Lindau 2025, he and Guido Imbens revisited core econometric tools—while a new generation explored fresh data sources like LinkedIn and AI. Der Beitrag Measuring What Works: The New Frontier of Econometrics erschien zuerst auf Lindau Nobel Laureate Meetings .